Asprosin-driven metabolic-epigenetic rewiring attenuates mesenchymal stem cell senescence with therapeutic benefits for infarcted hearts
Open Access
- 30 January 2026
- journal article
- Published by Elsevier in Journal of Advanced Research
- Vol. 88, 1055-1075
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (U23A6011)
- National Natural Science Foundation of China (82400360)
This publication has 69 references indexed in Scilit:
- Lactylation modification in cardio-cerebral diseases: A state-of-the-art reviewAgeing Research Reviews, 2024
- Lactate promotes H3K18 lactylation in human neuroectoderm differentiationCellular and Molecular Life Sciences, 2024
- Adiponectin restores the obesity-induced impaired immunomodulatory function of mesenchymal stromal cells via glycolytic reprogrammingActa Pharmaceutica Sinica B, 2023
- Asprosin Exacerbates Endothelium Inflammation Induced by Hyperlipidemia Through Activating IKKβ-NF-κBp65 PathwayInflammation, 2022
- Sex‐Specific Effects of Maternal and Post‐Weaning High‐Fat Diet on Adipose Tissue Remodeling and Asprosin Expression in Mice OffspringMolecular Nutrition & Food Research, 2021
- A common signature of cellular senescence; does it exist?Ageing Research Reviews, 2021
- Discrepancies on the Role of Oxygen Gradient and Culture Condition on Mesenchymal Stem Cell FateAdvanced Healthcare Materials, 2021
- Pre-culture of mesenchymal stem cells within RGD-modified hyaluronic acid hydrogel improves their resilience to ischaemic conditionsActa Biomaterialia, 2020
- RecQ helicases and PARP1 team up in maintaining genome integrityAgeing Research Reviews, 2015
- Fibrillin-1 Regulates Skeletal Stem Cell Differentiation by Modulating TGFβ Activity Within the Marrow NicheJournal of Bone and Mineral Research, 2015